These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36839750)

  • 1. Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment.
    Chen Z; Rong Y; Ding J; Cheng X; Chen X; He C
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of an Injectable Polypeptide Hydrogel Depot Containing the Immune Checkpoint Blocker Anti-PD-L1 and Doxorubicin to Enhance Antitumor Combination Therapy.
    Shi Y; Li D; He C; Chen X
    Macromol Biosci; 2021 Jun; 21(6):e2100049. PubMed ID: 33871152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-responsive thermosensitive polypeptide hydrogels for localized drug delivery and improved tumor chemoimmunotherapy.
    Li F; Ding J; Li Z; Rong Y; He C; Chen X
    Biomater Sci; 2024 Jun; 12(12):3100-3111. PubMed ID: 38712522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
    Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
    Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs.
    Wei L; Chen J; Zhao S; Ding J; Chen X
    Acta Biomater; 2017 Aug; 58():44-53. PubMed ID: 28576715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody.
    Wu H; Wei G; Luo L; Li L; Gao Y; Tan X; Wang S; Chang H; Liu Y; Wei Y; Song J; Zhang Z; Huo J
    Biomater Res; 2022 Dec; 26(1):77. PubMed ID: 36494759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hollow gold nanoshells-incorporated injectable genetically engineered hydrogel for sustained chemo-photothermal therapy of tumor.
    Jin R; Yang J; Zhao D; Hou X; Li C; Chen W; Zhao Y; Yin Z; Liu B
    J Nanobiotechnology; 2019 Sep; 17(1):99. PubMed ID: 31530285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment.
    Lv Q; He C; Quan F; Yu S; Chen X
    Bioact Mater; 2018 Mar; 3(1):118-128. PubMed ID: 29744449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation.
    Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G
    ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferritin-Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy.
    Liu R; Liang Q; Luo JQ; Li YX; Zhang X; Fan K; Du JZ
    Adv Sci (Weinh); 2024 Jan; 11(3):e2305217. PubMed ID: 38029345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer.
    Won JE; Wi TI; Lee CM; Lee JH; Kang TH; Lee JW; Shin BC; Lee Y; Park YM; Han HD
    Acta Biomater; 2021 Dec; 136():508-518. PubMed ID: 34626819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear-responsive injectable supramolecular hydrogel releasing doxorubicin loaded micelles with pH-sensitivity for local tumor chemotherapy.
    Liu Z; Xu G; Wang C; Li C; Yao P
    Int J Pharm; 2017 Sep; 530(1-2):53-62. PubMed ID: 28739501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programming Injectable DNA Hydrogels Yields Tumor Microenvironment-Activatable and Immune-Instructive Depots for Augmented Chemo-Immunotherapy.
    Fan Y; Zhan M; Liang J; Yang X; Zhang B; Shi X; Hu Y
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302119. PubMed ID: 37541435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor immunity triggered by photothermal therapy and photodynamic therapy of a 2D MoS
    Jin R; Yang J; Ding P; Li C; Zhang B; Chen W; Zhao YD; Cao Y; Liu B
    Nanotechnology; 2020 May; 31(20):205102. PubMed ID: 32018232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
    Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
    Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
    Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
    J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable polypeptide-engineered hydrogel depot for amplifying the anti-tumor immune effect induced by chemo-photothermal therapy.
    Hou XL; Dai X; Yang J; Zhang B; Zhao DH; Li CQ; Yin ZY; Zhao YD; Liu B
    J Mater Chem B; 2020 Sep; 8(37):8623-8633. PubMed ID: 32821893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
    Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
    J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.